BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ganta NM, Gedda G, Rathnakar B, Satyanarayana M, Yamajala B, Ahsan MJ, Jadav SS, Balaraju T. A review on HCV inhibitors: Significance of non-structural polyproteins. Eur J Med Chem 2019;164:576-601. [PMID: 30639895 DOI: 10.1016/j.ejmech.2018.12.045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Meshram RJ, Kathwate GH, Gacche RN. Progress, evolving therapeutic/diagnostic approaches, and challenges in the management of hepatitis C virus infections. Arch Virol 2022. [PMID: 35089390 DOI: 10.1007/s00705-022-05375-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
2 Han D, Wang H, Wujieti B, Zhang B, Cui W, Chen BZ. Insight into the drug resistance mechanisms of GS-9669 caused by mutations of HCV NS5B polymerase via molecular simulation. Comput Struct Biotechnol J 2021;19:2761-74. [PMID: 34093991 DOI: 10.1016/j.csbj.2021.04.026] [Reference Citation Analysis]
3 da Silva EM, Vidal HDA, Corrêa AG. Advances on Greener Asymmetric Synthesis of Antiviral Drugs via Organocatalysis. Pharmaceuticals (Basel) 2021;14:1125. [PMID: 34832907 DOI: 10.3390/ph14111125] [Reference Citation Analysis]
4 Skwarecki AS, Nowak MG, Milewska MJ. Amino Acid and Peptide-Based Antiviral Agents. ChemMedChem 2021. [PMID: 34254457 DOI: 10.1002/cmdc.202100397] [Reference Citation Analysis]
5 Barakat K, Ahmed M, Tabana Y, Ha M. A 'deep dive' into the SARS-Cov-2 polymerase assembly: identifying novel allosteric sites and analyzing the hydrogen bond networks and correlated dynamics. J Biomol Struct Dyn 2021;:1-21. [PMID: 34034620 DOI: 10.1080/07391102.2021.1930162] [Reference Citation Analysis]
6 Hwu JR, Kapoor M, Gupta NK, Tsay S, Huang W, Tan K, Hu Y, Lyssen P, Neyts J. Synthesis and antiviral activities of quinazolinamine–coumarin conjugates toward chikungunya and hepatitis C viruses. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hdoufane I, Bjij I, Oubahmane M, Soliman MES, Villemin D, Cherqaoui D. In silico design and analysis of NS4B inhibitors against hepatitis C virus. J Biomol Struct Dyn 2020;:1-15. [PMID: 33118481 DOI: 10.1080/07391102.2020.1839561] [Reference Citation Analysis]
8 Ezat AA, Elfiky AA, Elshemey WM, Saleh NA. Novel inhibitors against wild-type and mutated HCV NS3 serine protease: an in silico study. Virusdisease 2019;30:207-13. [PMID: 31179358 DOI: 10.1007/s13337-019-00516-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 G AC, Gondru R, Li Y, Banothu J. Coumarin-benzimidazole hybrids: A review of developments in medicinal chemistry. Eur J Med Chem 2022;227:113921. [PMID: 34715585 DOI: 10.1016/j.ejmech.2021.113921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]